Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.23)
# 1,162
Out of 4,413 analysts
19
Total ratings
54.55%
Success rate
1.09%
Average return
Main Sectors:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $15.88 | +151.89% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.17 | +127.79% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $6.61 | +28.59% | 3 | Aug 3, 2023 | |
| UTHR United Therapeutics | Maintains: Buy | $256 → $268 | $255.14 | +5.04% | 3 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $18.31 | -12.62% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $119 | $0.55 | +21,734.86% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $1.13 | +1,935.40% | 1 | Jun 29, 2022 | |
| RPHM Reneo Pharmaceuticals | Initiates: Buy | n/a | $1.71 | - | 1 | Nov 22, 2021 | |
| LPCN Lipocine | Upgrades: Buy | n/a | $4.71 | - | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | n/a | $6.93 | - | 1 | Oct 14, 2020 | |
| TARA Protara Therapeutics | Initiates: Buy | n/a | $2.93 | - | 1 | Jan 22, 2020 |
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $15.88
Upside: +151.89%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.17
Upside: +127.79%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $6.61
Upside: +28.59%
United Therapeutics
Aug 3, 2023
Maintains: Buy
Price Target: $256 → $268
Current: $255.14
Upside: +5.04%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $18.31
Upside: -12.62%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $119
Current: $0.55
Upside: +21,734.86%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $1.13
Upside: +1,935.40%
Reneo Pharmaceuticals
Nov 22, 2021
Initiates: Buy
Price Target: n/a
Current: $1.71
Upside: -
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $4.71
Upside: -
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: n/a
Current: $6.93
Upside: -
Protara Therapeutics
Jan 22, 2020
Initiates: Buy
Price Target: n/a
Current: $2.93
Upside: -